iGeneTech: Ten years of evolution, all for better target gene enrichment, founded in Beijing in 2014, is a biotechnology company. With intellectual property rights, there are three major technology platforms: NGS probe hybridization, multiplex PCR primer design, and high-throughput oligo pools synthesis. A high-tech enterprise certified by ISO 13485 and ISO 9001 quality management systems, that provides customized gene capture products for fields such as tumor companion diagnosis, multi-cancer early detection, breeding chips, pathogen monitoring, etc.